223 related articles for article (PubMed ID: 33158638)
1. Intraoperative detection of colorectal and pancreatic liver metastases using SGM-101, a fluorescent antibody targeting CEA.
Meijer RPJ; de Valk KS; Deken MM; Boogerd LSF; Hoogstins CES; Bhairosingh SS; Swijnenburg RJ; Bonsing BA; Framery B; Fariña Sarasqueta A; Putter H; Hilling DE; Burggraaf J; Cailler F; Mieog JSD; Vahrmeijer AL
Eur J Surg Oncol; 2021 Mar; 47(3 Pt B):667-673. PubMed ID: 33158638
[TBL] [Abstract][Full Text] [Related]
2. SGM-101: An innovative near-infrared dye-antibody conjugate that targets CEA for fluorescence-guided surgery.
Gutowski M; Framery B; Boonstra MC; Garambois V; Quenet F; Dumas K; Scherninski F; Cailler F; Vahrmeijer AL; Pèlegrin A
Surg Oncol; 2017 Jun; 26(2):153-162. PubMed ID: 28577721
[TBL] [Abstract][Full Text] [Related]
3. Safety and effectiveness of SGM-101, a fluorescent antibody targeting carcinoembryonic antigen, for intraoperative detection of colorectal cancer: a dose-escalation pilot study.
Boogerd LSF; Hoogstins CES; Schaap DP; Kusters M; Handgraaf HJM; van der Valk MJM; Hilling DE; Holman FA; Peeters KCMJ; Mieog JSD; van de Velde CJH; Farina-Sarasqueta A; van Lijnschoten I; Framery B; Pèlegrin A; Gutowski M; Nienhuijs SW; de Hingh IHJT; Nieuwenhuijzen GAP; Rutten HJT; Cailler F; Burggraaf J; Vahrmeijer AL
Lancet Gastroenterol Hepatol; 2018 Mar; 3(3):181-191. PubMed ID: 29361435
[TBL] [Abstract][Full Text] [Related]
4. Image-Guided Surgery in Patients with Pancreatic Cancer: First Results of a Clinical Trial Using SGM-101, a Novel Carcinoembryonic Antigen-Targeting, Near-Infrared Fluorescent Agent.
Hoogstins CES; Boogerd LSF; Sibinga Mulder BG; Mieog JSD; Swijnenburg RJ; van de Velde CJH; Farina Sarasqueta A; Bonsing BA; Framery B; Pèlegrin A; Gutowski M; Cailler F; Burggraaf J; Vahrmeijer AL
Ann Surg Oncol; 2018 Oct; 25(11):3350-3357. PubMed ID: 30051369
[TBL] [Abstract][Full Text] [Related]
5. Carcinoembryonic antigen-specific, fluorescent image-guided cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for metastatic colorectal cancer.
Schaap DP; de Valk KS; Deken MM; Meijer RPJ; Burggraaf J; Vahrmeijer AL; Kusters M;
Br J Surg; 2020 Mar; 107(4):334-337. PubMed ID: 31960953
[TBL] [Abstract][Full Text] [Related]
6. Multimodal CEA-Targeted Image-Guided Colorectal Cancer Surgery using
de Gooyer JM; Elekonawo FMK; Bos DL; van der Post RS; Pèlegrin A; Framery B; Cailler F; Vahrmeijer AL; de Wilt JHW; Rijpkema M
Clin Cancer Res; 2020 Nov; 26(22):5934-5942. PubMed ID: 32900795
[TBL] [Abstract][Full Text] [Related]
7. Effective fluorescence-guided surgery of liver metastasis using a fluorescent anti-CEA antibody.
Hiroshima Y; Lwin TM; Murakami T; Mawy AA; Kuniya T; Chishima T; Endo I; Clary BM; Hoffman RM; Bouvet M
J Surg Oncol; 2016 Dec; 114(8):951-958. PubMed ID: 27696448
[TBL] [Abstract][Full Text] [Related]
8. Fluorescent-guided surgery for sentinel lymph node detection in gastric cancer and carcinoembryonic antigen targeted fluorescent-guided surgery in colorectal and pancreatic cancer.
Vuijk FA; Hilling DE; Mieog JSD; Vahrmeijer AL
J Surg Oncol; 2018 Aug; 118(2):315-323. PubMed ID: 30216455
[TBL] [Abstract][Full Text] [Related]
9. High-Precision Quantitative Analysis Reveals Carcinoembryonic Protein Expression Differs Among Colorectal Cancer Primary Foci and Metastases to Different Sites.
Zhu Y; Zhang Q; Wei C; Hu Y; Gong H; Liu Y; Lai H; Feng Y; Lin Y
Technol Cancer Res Treat; 2021; 20():15330338211037175. PubMed ID: 34342245
[TBL] [Abstract][Full Text] [Related]
10. Carcinoembryonic Antigen-Related Cell Adhesion Molecule Type 5 Receptor-Targeted Fluorescent Intraoperative Molecular Imaging Tracer for Lung Cancer: A Nonrandomized Controlled Trial.
Azari F; Meijer RPJ; Kennedy GT; Hanna A; Chang A; Nadeem B; Din A; Pèlegrin A; Framery B; Cailler F; Sullivan NT; Kucharczuk J; Martin LW; Vahrmeijer AL; Singhal S
JAMA Netw Open; 2023 Jan; 6(1):e2252885. PubMed ID: 36705924
[TBL] [Abstract][Full Text] [Related]
11. Dose escalation trial of indium-111-labeled anti-carcinoembryonic antigen chimeric monoclonal antibody (chimeric T84.66) in presurgical colorectal cancer patients.
Wong JY; Chu DZ; Yamauchi D; Odom-Maryon TL; Williams LE; Liu A; Esteban JM; Wu AM; Primus FJ; Beatty JD; Shively JE; Raubitschek AA
J Nucl Med; 1998 Dec; 39(12):2097-104. PubMed ID: 9867150
[TBL] [Abstract][Full Text] [Related]
12. Toxicity and pharmacokinetic profile of SGM-101, a fluorescent anti-CEA chimeric antibody for fluorescence imaging of tumors in patients.
Framery B; Gutowski M; Dumas K; Evrard A; Muller N; Dubois V; Quinonero J; Scherninski F; Pèlegrin A; Cailler F
Toxicol Rep; 2019; 6():409-415. PubMed ID: 31080749
[TBL] [Abstract][Full Text] [Related]
13. Dose-Finding Study of a CEA-Targeting Agent, SGM-101, for Intraoperative Fluorescence Imaging of Colorectal Cancer.
de Valk KS; Deken MM; Schaap DP; Meijer RP; Boogerd LS; Hoogstins CE; van der Valk MJ; Kamerling IM; Bhairosingh SS; Framery B; Hilling DE; Peeters KC; Holman FA; Kusters M; Rutten HJ; Cailler F; Burggraaf J; Vahrmeijer AL
Ann Surg Oncol; 2021 Mar; 28(3):1832-1844. PubMed ID: 33034788
[TBL] [Abstract][Full Text] [Related]
14. Preclinical evaluation of a novel CEA-targeting near-infrared fluorescent tracer delineating colorectal and pancreatic tumors.
Boonstra MC; Tolner B; Schaafsma BE; Boogerd LS; Prevoo HA; Bhavsar G; Kuppen PJ; Sier CF; Bonsing BA; Frangioni JV; van de Velde CJ; Chester KA; Vahrmeijer AL
Int J Cancer; 2015 Oct; 137(8):1910-20. PubMed ID: 25895046
[TBL] [Abstract][Full Text] [Related]
15. Fluorophore-conjugated anti-CEA antibody for the intraoperative imaging of pancreatic and colorectal cancer.
Kaushal S; McElroy MK; Luiken GA; Talamini MA; Moossa AR; Hoffman RM; Bouvet M
J Gastrointest Surg; 2008 Nov; 12(11):1938-50. PubMed ID: 18665430
[TBL] [Abstract][Full Text] [Related]
16. Fluorescence imaging after intraoperative intravenous injection of indocyanine green for detection of lymph node metastases in colorectal cancer.
Liberale G; Vankerckhove S; Galdon MG; Donckier V; Larsimont D; Bourgeois P
Eur J Surg Oncol; 2015 Sep; 41(9):1256-60. PubMed ID: 26081552
[TBL] [Abstract][Full Text] [Related]
17. Fluorescence-guided surgery with a fluorophore-conjugated antibody to carcinoembryonic antigen (CEA), that highlights the tumor, improves surgical resection and increases survival in orthotopic mouse models of human pancreatic cancer.
Metildi CA; Kaushal S; Pu M; Messer KA; Luiken GA; Moossa AR; Hoffman RM; Bouvet M
Ann Surg Oncol; 2014 Apr; 21(4):1405-11. PubMed ID: 24499827
[TBL] [Abstract][Full Text] [Related]
18. Molecular fluorescence-guided surgery of peritoneal carcinomatosis of colorectal origin: a single-centre feasibility study.
Harlaar NJ; Koller M; de Jongh SJ; van Leeuwen BL; Hemmer PH; Kruijff S; van Ginkel RJ; Been LB; de Jong JS; Kats-Ugurlu G; Linssen MD; Jorritsma-Smit A; van Oosten M; Nagengast WB; Ntziachristos V; van Dam GM
Lancet Gastroenterol Hepatol; 2016 Dec; 1(4):283-290. PubMed ID: 28404198
[TBL] [Abstract][Full Text] [Related]
19. A Novel Color-Coded Liver Metastasis Mouse Model to Distinguish Tumor and Adjacent Liver Segment.
Nishino H; Hollandsworth HM; Amirfakhri S; Tashiro Y; Yamamoto J; Turner MA; Lwin TM; Singer BB; Hoffman RM; Bouvet M
J Surg Res; 2021 Aug; 264():327-333. PubMed ID: 33848831
[TBL] [Abstract][Full Text] [Related]
20. Intraoperative molecular imaging of colorectal lung metastases with SGM-101: a feasibility study.
Meijer RPJ; Galema HA; Faber RA; Bijlstra OD; Maat APWM; Cailler F; Braun J; Keereweer S; Hilling DE; Burggraaf J; Vahrmeijer AL; Hutteman M;
Eur J Nucl Med Mol Imaging; 2023 Aug; ():. PubMed ID: 37552367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
